Lorena Blanco Selected Research

Renal Cell Carcinoma (Grawitz Tumor)

1/2016	The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases.
5/2013	Cannabinoid CB1 receptor is expressed in chromophobe renal cell carcinoma and renal oncocytoma.
12/2012	The impact of peptidase activity on clear cell renal cell carcinoma survival.
12/2010	Angiotensin-converting enzymes (ACE and ACE2) are downregulated in renal tumors.
12/2010	Cannabinoid CB₁ receptor is downregulated in clear cell renal cell carcinoma.
5/2010	Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependent.
4/2010	Changes in cell-surface peptidase activity in papillary renal cell carcinoma.
4/2008	Acid, basic, and neutral peptidases present different profiles in chromophobe renal cell carcinoma and in oncocytoma.
12/2007	Cystinyl aminopeptidase activity is decreased in renal cell carcinomas.
2/2007	Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lorena Blanco Research Topics

Disease

15	Neoplasms (Cancer) 01/2016 - 02/2007
10	Renal Cell Carcinoma (Grawitz Tumor) 01/2016 - 02/2007
5	Kidney Neoplasms (Kidney Cancer) 05/2014 - 02/2007
4	Colorectal Neoplasms (Colorectal Cancer) 06/2015 - 01/2014
2	Neoplasm Metastasis (Metastasis) 01/2016 - 01/2014
2	Adenoma (Adenomas) 06/2015 - 01/2015
2	Adenocarcinoma 06/2015 - 01/2015
2	Carcinogenesis 01/2015 - 12/2010
2	renal Oncocytoma 05/2013 - 12/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2016
1	Tuberculosis (Tuberculoses) 09/2016
1	Lymphatic Metastasis 01/2016
1	Hyperplasia 01/2013
1	Thyroid Neoplasms (Thyroid Cancer) 01/2013
1	Squamous Cell Carcinoma of Head and Neck 10/2009
1	Oxyphilic Adenoma (Oncocytoma) 04/2008

Drug/Important Bio-Agent (IBA)

12	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 02/2007
8	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2007
7	EnzymesIBA 06/2015 - 12/2007
7	Messenger RNA (mRNA)IBA 06/2015 - 05/2010
3	CD13 Antigens (Alanine Aminopeptidase)IBA 06/2015 - 02/2007
3	aminopeptidase BIBA 01/2015 - 02/2007
3	Pyroglutamyl-Peptidase IIBA 01/2015 - 02/2007
3	Glutamyl Aminopeptidase (Aspartyl Aminopeptidase)IBA 05/2014 - 02/2007
3	Prolyl OligopeptidasesIBA 01/2014 - 08/2010
3	AcidsIBA 10/2009 - 02/2007
2	enkephalin degrading enzymeIBA 01/2015 - 02/2007
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2015 - 01/2013
2	CannabinoidsIBA 05/2013 - 12/2010
1	AlbuminsIBA 09/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Serine (L-Serine)FDA Link 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2015
1	Tumor Biomarkers (Tumor Markers)IBA 01/2015
1	Phenobarbital (Luminal)FDA Link 01/2015
1	Calcibiotic Root Canal SealerIBA 01/2015
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 05/2013
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 05/2013
1	AngiotensinsIBA 12/2010
1	Formaldehyde (Formol)FDA Link 12/2010
1	EndocannabinoidsIBA 12/2010
1	Glycoproteins (Glycoprotein)IBA 05/2010
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 05/2010
1	AminopeptidasesIBA 10/2009
1	Cystinyl AminopeptidaseIBA 12/2007
1	Peptides (Polypeptides)IBA 02/2007

Therapy/Procedure

1	Biological Therapy 09/2016
1	Therapeutics 09/2016
1	Radiotherapy 01/2014